Schedule 13G ownership disclosure

ACADIA Pharmaceuticals Inc

Security class unavailable · CUSIP: 004225108

Event date: 2014-04-24

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,958,861
Percent of class
5.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001103804-14-000020
Form type
SC 13G
Filer
ACADIA PHARMACEUTICALS INC
CIK
CIK 1070494
Filed
May 05, 2014
Reporting period
Apr 24, 2014
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub